Xiaoming Bai

101 Longmian Avenue
Nanjing, 211166, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

SMYD3 synergises with RACK1 to promote colorectal cancer lung metastasis by recruiting SMAD3.

SMYD3 synergises with RACK1 to promote colorectal cancer lung metastasis by recruiting SMAD3.

Journal: Cell communication and signaling : CCS

Published: April 16, 2025

The inhibitory effect and targets of CRM197 on tumor growth in arsenic-transformed cells and lung cancer cells.

The inhibitory effect and targets of CRM197 on tumor growth in arsenic-transformed cells and lung cancer cells.

Journal: Scientific reports

Published: February 17, 2025

SLC7A5/E2F1/PTBP1/PKM2 axis mediates progression and therapy effect of triple-negative breast cancer through the crosstalk of amino acid metabolism and glycolysis pathway.

SLC7A5/E2F1/PTBP1/PKM2 axis mediates progression and therapy effect of triple-negative breast cancer through the crosstalk of amino acid metabolism and glycolysis pathway.

Journal: Cancer letters

Published: January 20, 2025

Effect of elevated CEA levels on the outcome of colorectal cancer patients with different histopathologic types:A SEER population-based study.

Effect of elevated CEA levels on the outcome of colorectal cancer patients with different histopathologic types:A SEER population-based study.

Journal: Biomolecules & biomedicine

Published: September 07, 2024

Osteosarcoma Cell-Derived Migrasomes Promote Macrophage M2 Polarization to Aggravate Osteosarcoma Proliferation and Metastasis.

Osteosarcoma Cell-Derived Migrasomes Promote Macrophage M2 Polarization to Aggravate Osteosarcoma Proliferation and Metastasis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 19, 2024

CBX3 promotes multidrug resistance by suppressing ferroptosis in colorectal carcinoma via the CUL3/NRF2/GPX2 axis.

CBX3 promotes multidrug resistance by suppressing ferroptosis in colorectal carcinoma via the CUL3/NRF2/GPX2 axis.

Journal: Oncogene

Published: August 18, 2024

Putative function and prognostic molecular marker of mast cells in colorectal cancer.

Putative function and prognostic molecular marker of mast cells in colorectal cancer.

Journal: BMC medical genomics

Published: April 15, 2024

Case report: successful response to bevacizumab combined with erlotinib for a novel FH gene mutation hereditary leiomyoma and renal cell carcinoma.

Case report: successful response to bevacizumab combined with erlotinib for a novel FH gene mutation hereditary leiomyoma and renal cell carcinoma.

Journal: Frontiers in pharmacology

Published: January 19, 2024

Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via TP53 and STAT3/ERK Signaling Pathways.

Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via TP53 and STAT3/ERK Signaling Pathways.

Journal: Annals of clinical and laboratory science

Published: January 05, 2024

The involvement of E3 ubiquitin ligases in the development and progression of colorectal cancer.

The involvement of E3 ubiquitin ligases in the development and progression of colorectal cancer.

Journal: Cell death discovery

Published: October 19, 2023

Bone tumor examination based on FCNN-4s and CRF fine segmentation fusion algorithm.

Bone tumor examination based on FCNN-4s and CRF fine segmentation fusion algorithm.

Journal: Journal of bone oncology

Published: May 08, 2023

Dehydrocostus lactone (DHC) promotes osteoblastic differentiation and mineralization through p38/RUNX-2 signaling.

Dehydrocostus lactone (DHC) promotes osteoblastic differentiation and mineralization through p38/RUNX-2 signaling.

Journal: Journal of biochemical and molecular toxicology

Published: March 07, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026